1 孙庆申,蔡雪晖. CD4和CD8分子在细胞免疫中的作用及其与PRRSV感染的关系[J]. 中国预防兽医学报,2002, 24(2):151~152. 2 闫若潜,谢彩华,吴志明,等. 鸡α干扰素/白细胞介素-2基因的融合表达及活性研究[J]. 中国农业科学,2010, 43(3):594~604. 3 闫若潜,马文涛,吴志明,等. 猪白细胞介素2/6嵌合基因的融合表达及活性[J]. 中国兽医学报,2012, 32(1):73~78. 4 吴志明,闫若潜,谢彩华,等. 猪白细胞介素-2的原核表达及其生物学活性研究[J].中国畜牧兽医, 2009, 36(4): 89~91. 5 程俊贞,闫若潜,吴志明,等. 重组鸡α干扰素/白细胞介素-2融合蛋白体内抗传染性法氏囊病病毒作用研究[J]. 中国预防兽医学报,2014,26(2):140~145. 6 Borjigin J,Li X D,Snyder S H,et al. The pineal gland and melatonin: Molecular and pharmacologic regulation[J].Annual Review of Pharmacology and Toxicology, 1999, 39(1):53~65. 7 Johnson H M, Bazer F W, Szente B E, et al. How interferons fight disease[J]. Scientific American, 1994, 270(5):68. 8 Legha S S. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy[J]. Seminars in Oncology, 1997, 24(Suppl 4):S39~S43. 9 Liao W, Lin J X, Leonard W J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy[J]. Immunity, 2013, 38(1):13~25. 10 Meager A. Biological assays for interferons[J]. Journal of Immunological Methods, 2002, 261(1):21~36. 11 Nelson B H. IL-2, regulatory T cells, and tolerance[J]. The Journal of Immunology, 2004, 172(7):3983~3988. 12 Prentice H G, Macdonald I D, Hamon M D. The role of immunotherapy in the treatment of acute myeloblastic leukemia: From allogeneic bone marrow transplantation to the application of interleukin 2[J]. Cancer Treat Res,1993,64:121~134. 13 Rigano R, Profumo E, Ioppolo S, et al. Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis[J]. Clin Exp Immunol, 1999, 115(3):503~507. 14 Robak T. Biological properties and therapeutic use of interleukin 2 (IL-2)[J]. Postepy Hig Med Dosw, 1994, 49(3):367~393. 15 Tossing G. Interferon-alpha in treatment of chronic hepatitis C in co-infected HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on Clinical Aspects and Treatment of HIV Infection (8th ECCATH), 29-31 October, Athens Greece[J]. European Journal of Medical Research, 2002, 7(1):44~46. |